USPTO serial 78285531
AVIDEX
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- COLEMAN, CIMMERIAN
- Law office
- OFFICE OF TRADEMARK PROGRAM CONTROL
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AVIDEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
OXFORDSHIRE, GB
OXFORDSHIRE, GB
Oxfordshire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Purvi J. Patel
PURVI J. PATEL HAYNES AND BOONE, LLP901 MAIN STREETSUITE 3100DALLAS, TX 75202-3789Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for medical use; pharmaceutical and biochemical substances and preparations, namely, small molecules, CD8O antagonists for the treatment of cancer and auto-immune diseases in vivo immunotherapeutic, inimunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use vaccines; protein conjugates for the treatment of cancer and auto-immune diseases diagnostic and analytical preparations for medical and veterinary use, namely, products that diagnose and analyze the effects of cancer and tissue damage caused by inflammation due to auto-immune diseases; gene therapy and cell therapy products, namely, T-cell receptors-- enzymes and enzyme preparations for medical purposes for the treatment of cancer and auto-immune diseases for clinical or medical use; chemical products for use in medical science, namely, T-cell receptors small molecules and protein therapeutics for clinical or medical use, pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer and auto-immune diseases | ABANDONED | — |
| 010 | Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring the spread of cancerous tissue, tissue damage or movement into affected limbs or organs; display apparatus, namely, multi-well plates and arrays for medical and clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors for medical purposes, medical and surgical syringes | ABANDONED | — |
| 042 | Biotechnology services, research and development in biotechnology, namely, product research and development for others in the field of biotechnology; scientific and medical research and development for others in the field of biotechnology and genomics, pharmaceutical drug development services and pharmaceutical product development; genetic engineering services, licensing intellectual property including trademarks and patents in the field of biotechnology | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MEDIGENE LIMITED
- Other trademarks owned by MEDIGENE LIMITED
- Other trademarks owned by Avidex Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named AVIDEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 25, 2008 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Aug 25, 2008 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Aug 19, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 8, 2008 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jul 30, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 11, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 10, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jul 10, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 9, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 9, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 2, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 27, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jun 16, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 9, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 16, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 28, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 8, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 8, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 6, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 19, 2007 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 23, 2007 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 21, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 21, 2006 | ALIE | ASSIGNED TO LIE | — |
| Apr 29, 2006 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Sep 14, 2005 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Feb 23, 2005 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 23, 2004 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Aug 12, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 26, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2004 | PAPER RECEIVED | — | |
| Jan 26, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2004 | DOCK | ASSIGNED TO EXAMINER | — |